top of page

Break cycles of infection and cure infection

HBVtech is a biopharma startup located in Frederick, MD. HBVtech focuses on research and development of a single injection-based hepatitis B drug to cure hepatitis B virus (HBV) infection.  HBV infection is a major infectious disease globally, with approximately 302 million people chronically infected and nearly one million die of HBV-related liver diseases each year.

Our Services

Science, Technologies and Products

Break cycles of infection and cure infection.  HBVtech is a biopharma startup located in Frederick, Maryland.  


Science behind the new HBV cure strategy.  Chronic HBV infection is conventionally thought to result from a continuation of unresolved initial HBV infection.


Technology Platform.

A sustained high level of endogenously expressed anti-HBs antibody is required to durably block new rounds of infection.


HBV product pipeline and development stage

Ready to find out more?

Contact HBVtech at any time for more information.  Or review our NEWS section for latest advances. 
bottom of page